Redeye provides a comment on the outcome in Respiratorius’ rights issue, announced earlier this afternoon. The offering was subscribed to 50%, of which c41% was subscribed with and without unit rights and the remainder represented guarantee commitments. Redeye reiterates its fair value range.

Link to the analysis